cvs health glp-1 receptor agonist weight management diabetes treatments Caremark is adding Zepbound, Eli Lilly's obesity drug, back to its commercial insurance plan formularies, more than a year after it stopped covering it in favor of Novo Nordisk's Wegovy. MORE Coverage, cost, and care

Although rates of acute pancreatitis have been low and similar between GLP-1 agonists and placebo in studies, caution is still warranted since acute pancreatitis carries a risk of recurrencewhich can turn into chronic pancreatitiswhich can increase risk of pancreatic cancer

A., Miners, J

Do GLP-1 agonists help with weight loss

6-10 GLP-1 receptor agonists work to lower glycemia via several mechanisms

One observational study conducted in the UK showed a 0.51% reduction in HbA1c and a 5.8-kg reduction in weight, with one in six patients discontinuing insulin after 26 weeks of exenatide-insulin combination therapy